Agammaglobulinemia, non-Bruton type: Clinical Trials

1 trial for Agammaglobulinemia, non-Bruton type, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Agammaglobulinemia, non-Bruton type: new trials by email Literature Review of Agammaglobulinemia, non-Bruton type trials Research Report on Agammaglobulinemia, non-Bruton type

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy
Human Normal Immunoglobulin for Subcutaneous Administration (IGSC) - Common Variable Immunodeficiency, X-linked Agammaglobulinemia
Phase 3CompletedCSL Behring512007-09-012011-09-01

Narrower conditions

Bruton type agammaglobulinemia (1)  ·  Common Variable Immunodeficiency (1)

Broader conditions

Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)

Interventions

Hizentra (1)  ·  gamma-Globulins (1)

Sponsors

CSL Behring (1)

Countries

France (1)  ·  Germany (1)  ·  Italy (1)  ·  Poland (1)  ·  Romania (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Stephen Jolles, MD (1)

Results publications

PMID 21674136, PMID 21705277